The Haemophilia Joint Health Score (HJHS) is a validated physical exam measure of haemophilic arthropathy, used clinically to determine treatment adequacy. Higher scores are worse; however, there is no...
Lire la suite

Artificial intelligence (AI) is increasingly explored in healthcare for its capacity to analyse complex data, support clinical decision-making and enable more personalised care. In haemophilia, AI is emerging...
Lire la suite

Haemophilia is often considered to predominantly affect malesdue to their X-linked mode of inheritance. For decades, womencarrying a pathogenic variant in the F8 or F9 gene were regardedmerely as 'carrier'...
Lire la suite

Gene therapy for Haemophilia B has received FDA approval, offering patients a transformative therapeutic option. However, effective communication about the benefits, risks, long-term efficacy and follow-up of gene therapy remains essential for informed decision-making. This study aimed to explore the diverse expectations, concerns and perspectives of patients with Haemophilia B, their caregivers and healthcare professionals (HCPs) regarding gene therapy...
Lire la suite